The diabetic patient is faced with many challenges in managing their condition and the least that providers can do for them is to make their lives easier. Discussing and prescribing pen delivery devices to use for insulin injection are major help we can provide.
The benefits of using devices are clear—pen devices are preferred by patients because they make insulin administration easy and convenient. They also offer lifestyle flexibility and reduced pain, both of which are considered likely to translate into enhanced quality of life and compliance. Remember, your patients reflect you in many ways and what you discuss or not discuss is what they will do.
I often ask providers what their preference would be if they had diabetes and all of them say they prefer pens over syringes. “What is good for the goose (physician) is also good for the gander (patients)” so unless cost is truly a barrier, there is no reason whatsoever to start insulin therapy with a vial/syringe.
The question as to which pen is more acceptable to patients is not what I intended to address here because I think that is a secondary issue when one looks at the big picture. As long as the pen device chosen is acceptable to patients and makes them comply more with treatment, the issue of which pen is used is of secondary importance, especially when larger insulin doses are delivered.
Therefore, I argue strongly that a pen device should be the first option offered to new insulin starters and that patients already using vials should also be offered the opportunity to convert to pens (unless they choose not to or there are other compelling reasons not to do so).
This can only happen if providers know about the new insulin pens available and are educated about them as well as feel comfortable using them. Any provider taking care of diabetic patients owes it to his/her patients to offer the best option, and in this situation (vials vs pens), there is a clear winner—pens.
The diabetic patient is faced with many challenges in managing their condition and the least that providers can do for them is to make their lives easier. Discussing and prescribing pen delivery devices to use for insulin injection are major help we can provide.
The benefits of using devices are clear—pen devices are preferred by patients because they make insulin administration easy and convenient. They also offer lifestyle flexibility and reduced pain, both of which are considered likely to translate into enhanced quality of life and compliance. Remember, your patients reflect you in many ways and what you discuss or not discuss is what they will do.
I often ask providers what their preference would be if they had diabetes and all of them say they prefer pens over syringes. “What is good for the goose (physician) is also good for the gander (patients)” so unless cost is truly a barrier, there is no reason whatsoever to start insulin therapy with a vial/syringe.
The question as to which pen is more acceptable to patients is not what I intended to address here because I think that is a secondary issue when one looks at the big picture. As long as the pen device chosen is acceptable to patients and makes them comply more with treatment, the issue of which pen is used is of secondary importance, especially when larger insulin doses are delivered.
Therefore, I argue strongly that a pen device should be the first option offered to new insulin starters and that patients already using vials should also be offered the opportunity to convert to pens (unless they choose not to or there are other compelling reasons not to do so).
This can only happen if providers know about the new insulin pens available and are educated about them as well as feel comfortable using them. Any provider taking care of diabetic patients owes it to his/her patients to offer the best option, and in this situation (vials vs pens), there is a clear winner—pens.
การแปล กรุณารอสักครู่..